Auto-antibodies against apolipoprotein A1 may neutralize the cardioprotective effect of the HDL complex, causing cardiovascular disease in SLE patients with anti-apolipoprotein A1 antibodies (136, 150). Here, APOA1 is linked to systemic lupus erythematosus.